Logo image of ACT

ENACT HOLDINGS INC (ACT) Stock Fundamental Analysis

NASDAQ:ACT - Nasdaq - US29249E1091 - Common Stock - Currency: USD

32.92  -0.26 (-0.78%)

After market: 32.92 0 (0%)

Fundamental Rating

5

Overall ACT gets a fundamental rating of 5 out of 10. We evaluated ACT against 101 industry peers in the Financial Services industry. ACT has only an average score on both its financial health and profitability. ACT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ACT was profitable.
ACT had a positive operating cash flow in the past year.
In the past 5 years ACT has always been profitable.
ACT had a positive operating cash flow in 4 of the past 5 years.
ACT Yearly Net Income VS EBIT VS OCF VS FCFACT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

The Return On Assets of ACT (10.35%) is better than 90.10% of its industry peers.
ACT's Return On Equity of 13.55% is in line compared to the rest of the industry. ACT outperforms 59.41% of its industry peers.
Industry RankSector Rank
ROA 10.35%
ROE 13.55%
ROIC N/A
ROA(3y)11.21%
ROA(5y)9.9%
ROE(3y)15.1%
ROE(5y)13.63%
ROIC(3y)N/A
ROIC(5y)N/A
ACT Yearly ROA, ROE, ROICACT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ACT's Profit Margin of 57.07% is amongst the best of the industry. ACT outperforms 95.05% of its industry peers.
In the last couple of years the Profit Margin of ACT has declined.
With an excellent Operating Margin value of 77.97%, ACT belongs to the best of the industry, outperforming 96.04% of the companies in the same industry.
In the last couple of years the Operating Margin of ACT has remained more or less at the same level.
Industry RankSector Rank
OM 77.97%
PM (TTM) 57.07%
GM N/A
OM growth 3Y5.43%
OM growth 5Y1.29%
PM growth 3Y5.4%
PM growth 5Y-3.72%
GM growth 3YN/A
GM growth 5YN/A
ACT Yearly Profit, Operating, Gross MarginsACT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

ACT has less shares outstanding than it did 1 year ago.
ACT has less shares outstanding than it did 5 years ago.
ACT has a better debt/assets ratio than last year.
ACT Yearly Shares OutstandingACT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACT Yearly Total Debt VS Total AssetsACT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

ACT has a debt to FCF ratio of 1.05. This is a very positive value and a sign of high solvency as it would only need 1.05 years to pay back of all of its debts.
ACT has a Debt to FCF ratio of 1.05. This is amongst the best in the industry. ACT outperforms 82.18% of its industry peers.
ACT has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
ACT has a Debt to Equity ratio of 0.15. This is in the better half of the industry: ACT outperforms 73.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.05
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
ACT Yearly LT Debt VS Equity VS FCFACT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ACT Yearly Current Assets VS Current LiabilitesACT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2021 2022 2023 5M 10M 15M 20M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.68% over the past year.
Measured over the past 5 years, ACT shows a small growth in Earnings Per Share. The EPS has been growing by 0.98% on average per year.
The Revenue has been growing slightly by 4.18% in the past year.
ACT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.19% yearly.
EPS 1Y (TTM)10.68%
EPS 3Y9.13%
EPS 5Y0.98%
EPS Q2Q%11.22%
Revenue 1Y (TTM)4.18%
Revenue growth 3Y2.44%
Revenue growth 5Y4.19%
Sales Q2Q%1.89%

3.2 Future

ACT is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.45% yearly.
ACT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.67% yearly.
EPS Next Y-4.09%
EPS Next 2Y-0.76%
EPS Next 3Y2.45%
EPS Next 5YN/A
Revenue Next Year2.85%
Revenue Next 2Y4.78%
Revenue Next 3Y4.67%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ACT Yearly Revenue VS EstimatesACT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ACT Yearly EPS VS EstimatesACT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.22, the valuation of ACT can be described as very cheap.
ACT's Price/Earnings ratio is rather cheap when compared to the industry. ACT is cheaper than 84.16% of the companies in the same industry.
When comparing the Price/Earnings ratio of ACT to the average of the S&P500 Index (29.63), we can say ACT is valued rather cheaply.
The Price/Forward Earnings ratio is 7.53, which indicates a rather cheap valuation of ACT.
Based on the Price/Forward Earnings ratio, ACT is valued a bit cheaper than the industry average as 79.21% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.68. ACT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.22
Fwd PE 7.53
ACT Price Earnings VS Forward Price EarningsACT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ACT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ACT is cheaper than 88.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.12
EV/EBITDA N/A
ACT Per share dataACT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)7.39
EPS Next 2Y-0.76%
EPS Next 3Y2.45%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.23%, ACT has a reasonable but not impressive dividend return.
ACT's Dividend Yield is a higher than the industry average which is at 3.84.
ACT's Dividend Yield is comparable with the S&P500 average which is at 2.29.
Industry RankSector Rank
Dividend Yield 2.23%

5.2 History

ACT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ACT Yearly Dividends per shareACT Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ACT pays out 32.55% of its income as dividend. This is a sustainable payout ratio.
DP32.55%
EPS Next 2Y-0.76%
EPS Next 3Y2.45%
ACT Yearly Income VS Free CF VS DividendACT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
ACT Dividend Payout.ACT Dividend Payout, showing the Payout Ratio.ACT Dividend Payout.PayoutRetained Earnings

ENACT HOLDINGS INC

NASDAQ:ACT (2/21/2025, 8:00:00 PM)

After market: 32.92 0 (0%)

32.92

-0.26 (-0.78%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners19.13%
Inst Owner Change4.64%
Ins Owners0.33%
Ins Owner Change-2.68%
Market Cap5.06B
Analysts78
Price Target40.03 (21.6%)
Short Float %6.15%
Short Ratio6.44
Dividend
Industry RankSector Rank
Dividend Yield 2.23%
Yearly Dividend1.32
Dividend Growth(5Y)N/A
DP32.55%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-21 2025-02-21 (0.185)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.03%
Min EPS beat(2)15.04%
Max EPS beat(2)27.01%
EPS beat(4)4
Avg EPS beat(4)13.83%
Min EPS beat(4)5.7%
Max EPS beat(4)27.01%
EPS beat(8)8
Avg EPS beat(8)16.14%
EPS beat(12)12
Avg EPS beat(12)19.88%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.38%
Min Revenue beat(2)-0.96%
Max Revenue beat(2)0.19%
Revenue beat(4)1
Avg Revenue beat(4)-1%
Min Revenue beat(4)-1.85%
Max Revenue beat(4)0.19%
Revenue beat(8)3
Avg Revenue beat(8)-0.57%
Revenue beat(12)4
Avg Revenue beat(12)-0.87%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.95%
PT rev (3m)0.38%
EPS NQ rev (1m)-0.16%
EPS NQ rev (3m)1.8%
EPS NY rev (1m)1.44%
EPS NY rev (3m)3.18%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)-1.87%
Revenue NY rev (3m)-1.64%
Valuation
Industry RankSector Rank
PE 7.22
Fwd PE 7.53
P/S 4.23
P/FCF 7.12
P/OCF 7.12
P/B 1
P/tB 1
EV/EBITDA N/A
EPS(TTM)4.56
EY13.85%
EPS(NY)4.37
Fwd EY13.28%
FCF(TTM)4.62
FCFY14.05%
OCF(TTM)4.62
OCFY14.05%
SpS7.79
BVpS32.79
TBVpS32.79
PEG (NY)N/A
PEG (5Y)7.39
Profitability
Industry RankSector Rank
ROA 10.35%
ROE 13.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 77.97%
PM (TTM) 57.07%
GM N/A
FCFM 59.37%
ROA(3y)11.21%
ROA(5y)9.9%
ROE(3y)15.1%
ROE(5y)13.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y5.43%
OM growth 5Y1.29%
PM growth 3Y5.4%
PM growth 5Y-3.72%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.05
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 104.03%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.68%
EPS 3Y9.13%
EPS 5Y0.98%
EPS Q2Q%11.22%
EPS Next Y-4.09%
EPS Next 2Y-0.76%
EPS Next 3Y2.45%
EPS Next 5YN/A
Revenue 1Y (TTM)4.18%
Revenue growth 3Y2.44%
Revenue growth 5Y4.19%
Sales Q2Q%1.89%
Revenue Next Year2.85%
Revenue Next 2Y4.78%
Revenue Next 3Y4.67%
Revenue Next 5YN/A
EBIT growth 1Y5.19%
EBIT growth 3Y8.01%
EBIT growth 5Y5.53%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y18.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.28%
OCF growth 3YN/A
OCF growth 5YN/A